Adlai Nortye Ltd.
ANLNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $505.35M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.88$17.25
- Volume (live)
- -
- Avg. volume (3M)
- 270.32K
Adlai Nortye (ANL) Stock Price & Financial Analysis
Adlai Nortye Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.30 - $10.65 |
|---|---|
| 52-Week High | $17.25 |
| 52-Week Low | $0.88 |
| Open | $10.55 |
| Volume (last close) | 79.54K |
| Average Volume (3M) | 270.32K |
| Revenue (TTM) | 19.68M |
|---|---|
| Net Income (TTM) | -22.53M |
| Free Cash Flow (TTM) | -58.25M |
| EPS (TTM) | −$1.69 |
| Profit Margin | -114.48% |
| Operating Margin | -113.28% |
| Return on Equity (ROE) | -10.49% |
| Debt to Equity | 0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 505.35M |
|---|---|
| Shares Outstanding | 47.76M |
| Price to Sales (P/S) | 25.68 |
| Price to Book (P/B) | 2.35 |
| EV/EBITDA | -18.56 |
| 50-Day MA | $14.30 |
|---|---|
| 200-Day MA | $11.03 |
| 1-Year Change | +537.35% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Adlai Nortye at a Glance
As of the Oct 23, 2026 close, Adlai Nortye (ANL) has a market capitalization of $505.35M. The stock trades at 25.7× sales. Over the trailing twelve months it lost $22.53M on revenue of $19.68M and burned $58.25M of free cash flow.
As of its latest reported balance sheet, it holds $132.59M in cash and securities against $25.71M of debt, a net cash position of $106.88M.
Adlai Nortye does not currently pay a dividend.
The share price is up 537.3% over the past year. At $10.58 (the Oct 23, 2026 close) it sits within its 52-week range of $0.88 to $17.25, below its 200-day moving average of $11.03.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $30.80, 191.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Adlai Nortye
What is the current stock price for ANL?
As of the Oct 23, 2026 close, ANL stock trades at $10.58. The 52-week range is $0.88–$17.25, with a day range of $10.30–$10.65.
What is the P/E ratio for ANL?
The P/E ratio (Price-to-Earnings) for ANL is shown in the Key Statistics section. This valuation metric helps compare Adlai Nortye Ltd. to industry peers.
Does ANL pay dividends?
Adlai Nortye does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANL?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for ANL is Buy. The average 12-month price target is $30.80, a 191.1% upside from the Oct 23, 2026 close of $10.58.
What is the market cap of ANL?
As of the Oct 23, 2026 close, Adlai Nortye's market capitalization is $505.4M, classifying it as a small-cap company. Adlai Nortye operates in the Healthcare sector within the Biotechnology industry.